- Is the Low-Thalidomide Dose MPT Regimen Beneficial?
-
Min CK
- KMID: 1729241
- Korean J Intern Med.
- 2011 Dec;26(4):400-402.
- doi: 10.3904/kjim.2011.26.4.400
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Rapidly Growing Interval Colon Cancer
-
Kim JH, Park MI
- KMID: 2373231
- Korean J Gastroenterol.
- 2015 May;65(5):326-329.
- doi: 10.4166/kjg.2015.65.5.326
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Optic Disc Edema Responding to Localized Anti-vascular Endothelial Growth Factor Treatment in a Patient with POEMS Syndrome
-
Song HB, Yu HG
- KMID: 2363813
- Korean J Ophthalmol.
- 2015 Oct;29(5):357-358.
- doi: 10.3341/kjo.2015.29.5.357
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Intravitreal Bevacizumab for the Treatment of Optic Disc Edema in a Patient with POEMS Syndrome
-
Kim DW, Kang SY, Bae HW, Hong S, Seong GJ, Kim CY
- KMID: 2363812
- Korean J Ophthalmol.
- 2015 Oct;29(5):354-356.
- doi: 10.3341/kjo.2015.29.5.354
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Massive Exudative Retinal Detachment Following Photodynamic Therapy and Intravitreal Bevacizumab Injection in Retinal Capillary Hemangioma
-
Kim HM, Park KH, Woo SJ
- KMID: 2363724
- Korean J Ophthalmol.
- 2015 Apr;29(2):143-145.
- doi: 10.3341/kjo.2015.29.2.143
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Serous Retinal Detachment Following Combined Photodynamic Therapy and Intravitreal Bevacizumab Injection
-
Kim EY, Kim JW, Kim JB, Lew HM
- KMID: 754732
- Korean J Ophthalmol.
- 2009 Jun;23(2):124-126.
- doi: 10.3341/kjo.2009.23.2.124
We report a case of serous retinal detachment following combined photodynamic therapy (PDT) and intravitreal bevacizumab injection in subfoveal choroidal neovascularization (CNV). -
- CITED
-
- Close
- SHARE
-
- Close
- A Comparative Study of Topical Mitomycin C, Cyclosporine, and Bevacizumab after Primary Pterygium Surgery
-
Hwang S, Choi S
- KMID: 2363844
- Korean J Ophthalmol.
- 2015 Dec;29(6):375-381.
- doi: 10.3341/kjo.2015.29.6.375
PURPOSE: To compare the recurrence rates and complications associated with instillation of topical mitomycin C, cyclosporine, and bevacizumab after primary pterygium surgery. METHODS: Between July 2013 and June 2014, we performed... -
- CITED
-
- Close
- SHARE
-
- Close
- Ranibizumab Injection for Corneal Neovascularization Refractory to Bevacizumab Treatment
-
Ahn YJ, Hwang HB, Chung SK
- KMID: 1792113
- Korean J Ophthalmol.
- 2014 Apr;28(2):177-180.
- doi: 10.3341/kjo.2014.28.2.177
Vascular endothelial growth factor inhibitor is an emerging therapeutic modality for various ocular diseases with neovascularization (NV). However, for corneal NV, controversy remains regarding whether bevacizumab or ranibizumab is superior.... -
- CITED
-
- Close
- SHARE
-
- Close
- Photodynamic Therapy Combined with Intravitreal Bevacizumab in a Patient with Choroidal Neovascularization Secondary to Choroidal Osteoma
-
Jang JH, Kim KH, Lee SJ, Park JM
- KMID: 1499690
- Korean J Ophthalmol.
- 2012 Dec;26(6):478-480.
- doi: 10.3341/kjo.2012.26.6.478
Choroidal osteoma is a benign ossified tumor that is found predominantly in healthy young women during their second and third decades of life. The lesions are white-to-cream or orange in... -
- CITED
-
- Close
- SHARE
-
- Close
- Cytomegalovirus Retinitis after Intravitreal Bevacizumab Injection in an Immunocompetent Patient
-
Bae SH, Kim TW, Chung H, Heo JW
- KMID: 1501800
- Korean J Ophthalmol.
- 2013 Feb;27(1):61-63.
- doi: 10.3341/kjo.2013.27.1.61
We report a case of cytomegalovirus (CMV) retinitis after intravitreal bevacizumab injection. A 61-year-old woman with diabetic macular edema developed dense vitritis and necrotizing retinitis 3 weeks after intravitreal bevacizumab... -
- CITED
-
- Close
- SHARE
-
- Close
- Aflibercept Treatment for Neovascular Age-related Macular Degeneration and Polypoidal Choroidal Vasculopathy Refractory to Anti-vascular Endothelial Growth Factor
-
Moon DR, Lee DK, Kim SH, You YS, Kwon OW
- KMID: 2363766
- Korean J Ophthalmol.
- 2015 Aug;29(4):226-232.
- doi: 10.3341/kjo.2015.29.4.226
PURPOSE: To report the results of switching treatment to vascular endothelial growth factor (VEGF) Trap-Eye (aflibercept) in neovascular age-related macular degeneration (AMD) and polypoidal choroidal vasculopathy (PCV) refractory to anti-VEGF... -
- CITED
-
- Close
- SHARE
-
- Close
- Comparison of Injection of Intravitreal Drugs with Standard Care in Macular Edema Secondary to Branch Retinal Vein Occlusion
-
Lee K, Jung H, Sohn J
- KMID: 1792090
- Korean J Ophthalmol.
- 2014 Feb;28(1):19-25.
- doi: 10.3341/kjo.2014.28.1.19
PURPOSE: To compare the long-term efficacy and safety of intravitreal triamcinolon with or without rescue laser therapy (intravitreal triamcinolone injection [IVTA] group), bevacizumab with or without rescue laser treatment (intravitreal... -
- CITED
-
- Close
- SHARE
-
- Close
- Influence of vascular endothelial growth factor inhibition on simple renal cysts in patients receiving bevacizumab-based chemotherapy
-
Grenader T, Shavit L
- KMID: 2359870
- Korean J Urol.
- 2015 Dec;56(12):791-795.
- doi: 10.4111/kju.2015.56.12.791
PURPOSE: Although angiogenesis has been implicated in the promotion of renal cyst growth in autosomal dominant polycystic kidney disease, no studies have investigated the role of angiogenesis in the growth... -
- CITED
-
- Close
- SHARE
-
- Close
- Liposomal honokiol, a potent anti-angiogenesis agent, in combination with radiotherapy produces a synergistic antitumor efficacy without increasing toxicity
-
Hu J, Chen LJ, Liu L, Chen X, Chen PL, Yang G, Hou WL, Tang MH, Zhang F, Wang XH, Zhao X, Wei YQ
- KMID: 1072942
- Exp Mol Med.
- 2008 Dec;40(6):617-628.
- doi: 10.3858/emm.2008.40.6.617
Honokiol is an active compound purified from magnolia that has been shown to induce cell differentiation, apoptosis, and anti-angiogenesis effects, as well as an enhancement in tumor growth delay in... -
- CITED
-
- Close
- SHARE
-
- Close
- Comparison of Systemic Adverse Events Associated with Intravitreal Anti-VEGF Injection: Ranibizumab versus Bevacizumab
-
Hwang DJ, Kim YW, Woo SJ, Park KH
- KMID: 2157986
- J Korean Med Sci.
- 2012 Dec;27(12):1580-1585.
- doi: 10.3346/jkms.2012.27.12.1580
The aim of this study was to compare the incidence of systemic adverse events in patients treated with intravitreal injections of bevacizumab or ranibizumab, and to evaluate whether compared to... -
- CITED
-
- Close
- SHARE
-
- Close
- Serum Concentration of Vascular Endothelial Growth Factor after Bilateral Intravitreal Injection of Bevacizumab
-
Wang D, Choi KS, Lee SJ
- KMID: 1792092
- Korean J Ophthalmol.
- 2014 Feb;28(1):32-38.
- doi: 10.3341/kjo.2014.28.1.32
PURPOSE: This study compared serum vascular endothelial growth factor (VEGF) concentration between patients given the bilateral and unilateral intravitreal injections of bevacizumab. METHODS: In a prospective manner, serum VEGF levels in... -
- CITED
-
- Close
- SHARE
-
- Close
- Clinical Outcomes of Eyes with Submacular Hemorrhage Secondary to Age-related Macular Degeneration Treated with Anti-vascular Endothelial Growth Factor
-
Kim KH, Kim JH, Chang YS, Lee TG, Kim JW, Lew YJ
- KMID: 2363805
- Korean J Ophthalmol.
- 2015 Oct;29(5):315-324.
- doi: 10.3341/kjo.2015.29.5.315
PURPOSE: To evaluate the long-term outcomes of intravitreal anti-vascular endothelial growth factor (VEGF) monotherapy for patients diagnosed with submacular hemorrhage secondary to exudative age-related macular degeneration. METHODS: This retrospective, observational study... -
- CITED
-
- Close
- SHARE
-
- Close
- High Dose Intravitreal Bevacizumab for Refractory Pigment Epithelial Detachment in Age-related Macular Degeneration
-
Lee DK, Kim SH, You YS, Kwon OW
- KMID: 2373986
- Korean J Ophthalmol.
- 2016 Aug;30(4):265-271.
- doi: 10.3341/kjo.2016.30.4.265
PURPOSE: Intravitreal anti-vascular endothelial growth factor (anti-VEGF) is the first choice of treatment for age-related macular degeneration. However, quite a few eyes treated using conventional dose anti-VEGF (CDAV) have persistent... -
- CITED
-
- Close
- SHARE
-
- Close
- Anti-VEGF-refractory Exudative Age-related Macular Degeneration: Differential Response According to Features on Optical Coherence Tomography
-
Shin JY, Woo SJ, Ahn J, Park KH
- KMID: 1792078
- Korean J Ophthalmol.
- 2013 Dec;27(6):425-432.
- doi: 10.3341/kjo.2013.27.6.425
PURPOSE: To describe optical coherence tomography (OCT) characteristics of neovascular age-related macular degeneration (AMD) patients refractory to intravitreal anti-vascular endothelial growth factor (VEGF) injections (ranibizumab, bevacizumab) and their responses to... -
- CITED
-
- Close
- SHARE
-
- Close
- Intravitreal Bevacizumab (Avastin) as an Adjuvant for the Treatment of Posterior Scleritis
-
Lim JW, Park JH
- KMID: 1018419
- Korean J Ophthalmol.
- 2011 Aug;25(4):282-284.
- doi: 10.3341/kjo.2011.25.4.282
We report a case of posterior scleritis effectively managed with intravitreal bevacizumab. A 71-year-old woman was diagnosed with posterior scleritis. Although she was initially treated with systemic steroids, her clinical... -
- CITED
-
- Close
- SHARE
-
- Close
